Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential?

BACKGROUND Nearly two decades after completion of the genome sequence of Mycobacterium tuberculosis (MTB), and with the advent of next generation sequencing technologies (NGS), whole-genome sequencing (WGS) has been applied to a wide range of clinical scenarios. Starting in 2017, England is the first country in the world to pioneer its use on a national scale for the diagnosis of tuberculosis, detection of drug resistance, and typing of MTB. AIMS This narrative review critically analyses the current applications of WGS for MTB and explains how close we are to realizing its full potential as a diagnostic, epidemiologic, and research tool. SOURCES We searched for reports (both original articles and reviews) published in English up to 31 May 2017, with combinations of the following keywords: whole-genome sequencing, Mycobacterium, and tuberculosis. MEDLINE, Embase, and Scopus were used as search engines. We included articles that covered different aspects of whole-genome sequencing in relation to MTB. CONTENT This review focuses on three main themes: the role of WGS for the prediction of drug susceptibility, MTB outbreak investigation and genetic diversity, and research applications of NGS. IMPLICATIONS Many of the original expectations have been accomplished, and we believe that with its unprecedented sensitivity and power, WGS has the potential to address many unanswered questions in the near future. However, caution is still needed when interpreting WGS data as there are some important limitations to be aware of, from correct interpretation of drug susceptibilities to the bioinformatic support needed.

[1]  Nalin Rastogi,et al.  Current Methods in the Molecular Typing of Mycobacterium tuberculosis and Other Mycobacteria , 2014, BioMed research international.

[2]  Phelim Bradley,et al.  Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples , 2016, Journal of Clinical Microbiology.

[3]  Faramarz Valafar,et al.  Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing , 2015, PloS one.

[4]  Stefan Niemann,et al.  Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological Study , 2013, PLoS medicine.

[5]  Ying Zhang,et al.  Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  B. Gicquel,et al.  Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature‐tagged transposon mutagenesis , 1999, Molecular microbiology.

[7]  I. Hoffman,et al.  Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. , 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  P. Massoure,et al.  Significance of the Identification in the Horn of Africa of an Exceptionally Deep Branching Mycobacterium tuberculosis Clade , 2012, PloS one.

[9]  M. Chase,et al.  Mycobacterium tuberculosis e Heterogeneity revealed through whole genome sequencing , 2012 .

[10]  P. V. van Helden,et al.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis , 2015, PloS one.

[11]  Stephen D. Bentley,et al.  Rapid Whole-Genome Sequencing for Investigation of a Suspected Tuberculosis Outbreak , 2012, Journal of Clinical Microbiology.

[12]  Karina Yusim,et al.  Mycobacterium tuberculosis--heterogeneity revealed through whole genome sequencing. , 2012, Tuberculosis.

[13]  M. Egger,et al.  Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. , 2015, The Journal of infectious diseases.

[14]  S. Cole,et al.  Tuberculosis drug discovery in the post-post-genomic era , 2014, EMBO molecular medicine.

[15]  V. Kovalev,et al.  The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis , 2017, Journal of Clinical Microbiology.

[16]  P. Sonnenberg,et al.  The prospective evaluation of the TB strain typing service in England: a mixed methods study , 2015, Thorax.

[17]  D. Sherman,et al.  Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis , 2013, PloS one.

[18]  R. Hartkoorn,et al.  Tuberculosis drugs: new candidates and how to find more. , 2011, Future microbiology.

[19]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[20]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[21]  Nicola J. Mulder,et al.  Function Prediction and Analysis of Mycobacterium tuberculosis Hypothetical Proteins , 2012, International journal of molecular sciences.

[22]  J. Palomino,et al.  Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. , 2011, The Journal of antimicrobial chemotherapy.

[23]  A. Witney,et al.  Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial , 2017, BMC Medicine.

[24]  Stefan Niemann,et al.  Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes , 2011 .

[25]  D. Behera,et al.  Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India , 2014, PloS one.

[26]  Phelim Bradley,et al.  Same-day diagnostic and surveillance data for tuberculosis via whole genome sequencing of direct respiratory samples , 2016 .

[27]  V. Danilenko,et al.  A Nonsynonymous SNP Catalog of Mycobacterium tuberculosis Virulence Genes and Its Use for Detecting New Potentially Virulent Sublineages , 2017, Genome biology and evolution.

[28]  Timothy D McHugh,et al.  Mycobacterium tuberculosis and whole genome sequencing: a practical guide and online tools available for the clinical microbiologist. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  Madhukar Pai,et al.  Tuberculosis diagnosis--time for a game change. , 2010, The New England journal of medicine.

[30]  Phelim Bradley,et al.  Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study , 2015, The Lancet. Infectious diseases.

[31]  S. Gillespie,et al.  Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture. , 2010, Journal of medical microbiology.

[32]  Julian Parkhill,et al.  Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study , 2016, PLoS medicine.

[33]  Gerst A. Gibbon.  A brief history of LIMS , 1996 .

[34]  A. Witney,et al.  Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance , 2016, BMC Medicine.

[35]  S. Gillespie,et al.  A Practical Guide to Measuring Mutation Rates in Antibiotic Resistance , 2008, Antimicrobial Agents and Chemotherapy.

[36]  Hinrich W. H. Göhlmann,et al.  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.

[37]  F. Drobniewski,et al.  Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  P. V. van Helden,et al.  The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates , 2016, Scientific Reports.

[39]  Jolyon Holdstock,et al.  Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples , 2015, Journal of Clinical Microbiology.

[40]  Thomas R Rogers,et al.  Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study , 2016, The Lancet. Respiratory medicine.

[41]  Rachel J. Williams,et al.  Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[42]  E. Rubin,et al.  Comprehensive identification of conditionally essential genes in mycobacteria , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Salzberg,et al.  Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains , 2002, Journal of bacteriology.

[44]  J. Farrar,et al.  Evaluation of the MTBDRsl Test for Detection of Second-Line-Drug Resistance in Mycobacterium tuberculosis , 2010, Journal of Clinical Microbiology.

[45]  F. Drobniewski,et al.  Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis. , 2015, International journal of antimicrobial agents.

[46]  R. Rappuoli,et al.  The impact of genomics on vaccine design. , 2005, Trends in biotechnology.

[47]  F. Cobelens,et al.  Impact on Patients’ Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial , 2015, PloS one.